Speaker:
Genevieve Crane,MD, PhD, MPhil, Cleveland Clinic Foundation
During this presentation, the audience will:
* Discuss how EBV-association may lower the mutational threshold for lymphomagenesis
* Relate host cell metabolic derangements caused by latent EBV infection to potential therapeutic vulnerabilities
* Hypothesize how host anti-tumor immune response could be enhanced in the setting of EBV-associated malignancies
Pathology Grand Rounds